LatestLabour’s ‘chaotic’ zero-hour crackdown could cost firms £3bn per year

Canadian business, markets & economy · Thursday, 13 August 2026

SM
Based in
Toronto
Stories
7

Journalist

Sophie Marchetti

Sophie Marchetti writes for CityAM Canada on Canadian business, markets, companies and the wider economy.

Areas of coverage

Business

Recent work by Sophie

  1. 13 Aug 2026

    Business

    Revolut's new airport lounges could benefit Canadian and US travelers

    Revolut will open its first airport lounge in Copenhagen in 2027, a step that could benefit North American travellers using the app.

  2. 12 Aug 2026

    Business

    Canada watches UK hire quantum chief despite no experience

    The UK government's new deputy head role for the Office for Quantum has sparked criticism for not requiring quantum expertise, a move that comes as Canada and the United States intensify their own quantum investments.

  3. 11 Aug 2026

    Business

    British firms face 70 per cent cost surge over decade as policy changes pile on overheads

    The British Chambers of Commerce says government decisions since 2016 have added roughly £827,000 a year to a typical mid-sized company's bill.

  4. 9 Aug 2026

    Business

    UK job seekers rise for 41st month as pressure builds on Burnham to ease hiring rules

    The pool of people looking for work in the UK has grown for nearly three and a half years while vacancies have fallen for 22 straight months.

  5. 9 Aug 2026

    Business

    Hargreaves Lansdown joins JPMorgan Chase in ordering staff back to office

    The UK investment platform will require three office days a week from January as major financial firms reverse pandemic-era flexibility.

  6. 6 Aug 2026

    Business

    Westminster Council proposes limits on standing drinks in Soho pubs

    London mayor Sadiq Khan opposes Conservative-led plan to restrict vertical drinking in the capital's nightlife district.

  7. 28 Jul 2026

    Business

    Nasdaq-listed Alkermes plc reports Q2 2026 results with major U.S. operations

    The Irish biopharma company, which runs R&D in Massachusetts and manufacturing in Ohio, released earnings and will hold a conference call today.